Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod 5% Cream for Genital or Perianal Warts in HIV+ Patients
NCT00761371Phase 4Completed
- Sponsor
- Meda
- Start
- Aug 2002
- Primary completion
- Feb 2004
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 4 trial of imiquimod in condylomata acuminata, sponsored by Meda. Started Aug 2002; status: completed.
02
Drugs
imiquimod
03
Conditions
condylomata acuminata
Beyond the preview
Go deeper on NCT00761371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761371.